Cupid, a contraceptives manufacturer, has seen a remarkable 620% rally in the past year, making it the costliest stock in its category with a P/E of 197. Despite strong fundamentals and technicals, experts advise caution for fresh investors due to its high valuation, suggesting partial profit-booking for existing shareholders.